Paragon 28 Inc
NYSE:FNA
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.78
14.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one FNA stock under the Base Case scenario is 17.14 USD. Compared to the current market price of 10.04 USD, Paragon 28 Inc is Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Paragon 28 Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for FNA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Paragon 28 Inc
Balance Sheet Decomposition
Paragon 28 Inc
Current Assets | 177.6m |
Cash & Short-Term Investments | 39.1m |
Receivables | 37.3m |
Other Current Assets | 101.2m |
Non-Current Assets | 124.4m |
PP&E | 74m |
Intangibles | 46.4m |
Other Non-Current Assets | 4m |
Current Liabilities | 50.7m |
Accounts Payable | 20.7m |
Accrued Liabilities | 27.4m |
Other Current Liabilities | 2.6m |
Non-Current Liabilities | 111.9m |
Long-Term Debt | 110m |
Other Non-Current Liabilities | 1.9m |
Earnings Waterfall
Paragon 28 Inc
Revenue
|
245m
USD
|
Cost of Revenue
|
-60.7m
USD
|
Gross Profit
|
184.3m
USD
|
Operating Expenses
|
-235.2m
USD
|
Operating Income
|
-50.9m
USD
|
Other Expenses
|
-12.2m
USD
|
Net Income
|
-63.1m
USD
|
Free Cash Flow Analysis
Paragon 28 Inc
USD | |
Free Cash Flow | USD |
FNA Profitability Score
Profitability Due Diligence
Paragon 28 Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Paragon 28 Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
FNA Solvency Score
Solvency Due Diligence
Paragon 28 Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Paragon 28 Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FNA Price Targets Summary
Paragon 28 Inc
According to Wall Street analysts, the average 1-year price target for FNA is 14.69 USD with a low forecast of 12.12 USD and a high forecast of 21 USD.
Dividends
Current shareholder yield for FNA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
FNA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 343 full-time employees. The company went IPO on 2021-10-15. The firm develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The firm has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The firm has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). The company has commercial footprint across United States and International.
Contact
IPO
Employees
Officers
The intrinsic value of one FNA stock under the Base Case scenario is 17.14 USD.
Compared to the current market price of 10.04 USD, Paragon 28 Inc is Undervalued by 41%.